Code | 9813B | ||||||||||
MA number | EU/1/14/971/008 | ||||||||||
Product Form: | sus ijp 1x263 mg (striek.inj.napl.+ 2 ihly) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU | ||||||||||
MAH, country: | Janssen - Cilag International N.V., Belgium | ||||||||||
Therapeutic Class: | 68 - ANTIPSYCHOTICA (NEUROLEPTICA) | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 24 | ||||||||||
Container: | pre-filled syringe | ||||||||||
Route of admin.: | Intramuscular use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 10c informed consent application |
MA issued: | 05.12.2014 |
SmPC + PL: |
|
Safety feature | Yes |
Data update: | 22.11.2019 |